GENE ONLINE|News &
Opinion
Blog

Deals
Novo Nordisk Acquires Lexicon’s LX9851 for $1B to Expand Weight Loss Drug Portfolio
2025-04-04
Bristol Myers Squibb Acquires Cancer Cell Therapy Partner 2seventy Bio in $286M Deal
2025-03-12
Gensaic Partners with Novo Nordisk in $354M Deal to Advance Precision Therapies for Cardiometabolic Diseases
2025-03-04
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
Teladoc Dials Up Virtual Care with $70 Million Acquisition of Catapult
2025-02-06
Eli Lilly Steals the Spotlight at JPM 2025 with $2.5 Billion Power Move Acquisition
2025-01-16
JPM 2025’s Billion Dollar Deal – GSK Bids Big in GI Cancer
2025-01-15
EY Predicts Smarter, Smaller M&A in Biotech and Pharma for 2025
2025-01-15
China’s Innovent Biologics Secures USD $1 Billion ADC Oncology Licensing Agreement with Roche
2025-01-06
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
Gilead Strikes Again: $415M Bet on ADCs with Tubulis Deal
2024-12-03
PuriBlood Breaks into Brazil: Partners with ABHH and Cromo to Conquer Latin America’s Largest Blood Market
2024-11-26
China’s Laekna Joins Forces with Weight-Loss Giant Lilly on Muscle-Preserving Obesity Drug in Expanding $150B Market
2024-11-21
CDMO Samsung Bio Secures Record $1.24 Billion Biopharma Manufacturing Contract, Raising Total 2024 Deal Value to Over $3.3 Billion
2024-10-23
1 2 3 13
LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top